| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 5001-18-3 | 1,3-金剛烷二醇; 1,3-二羥基金剛烷 | 1,3-Dihydroxyadamantane; 1,3-Adamantanediol(6CI,7CI,8CI); 1,3-Dihydroxy admantane; Tricyclo[3.3.1.13,7]decane-1,3-diol; |  | C10H16O2 | 詳情 | 供應商 |
| 19982-07-1 | 1-乙酰氨基-3,5-二甲基金剛烷 | 1-Actamido-3,5-dimethyladmantane; N-(3,5-Dimethyl-1-adamantyl)-acetamide |  | C14H23NO | 詳情 | 供應商 |
| 157371-80-7 | 3-(溴甲基)-2,4,10-三氧雜金剛烷 | 2,4,10-Trioxatricyclo[3.3.1.13,7]decane,3-(bromomethyl)-; 3-(BROMOMETHYL)-2,4, 10-TRIOXAADAMANTANE; 3-(BROMOMETHYL)-2,4, 10-TRIOXATRICYCLO[3.3.1.1(3.7)]DECANE; BROMO(2,3, 10-TRIOXATRICYCLO[3.3.1.1(3.7)]DEC-3-YL)METHANE; 3-(bromomethyl)-2,4,10-trioxatricyclo(3. 3.1.1(3)(.)(7))dec.; 3-(Bromomethyl)-2,4,10-trioxaadmantane; 2,4,10-Trioxatricyclo3.3.1.13,7decane, 3-(bromomethyl)-; 3-(Bromomethyl)-2,4,10-trioxatricyclo[3.3.1.13.7]decane, Bromo(2,3,10-trioxatricyclo[3.3.1.13.7]dec-3-yl)methane; 3-(Bromomethyl)-2,4,10-trioxaadamantane, Bromo(2,3,10-trioxatricyclo[3.3.1.13.7]dec-3-yl)methane |  | C8H11BrO3 | 詳情 | 供應商 |
| 130942-96-0 | (1-腺嘌呤乙酰基-D-精氨酸0,羥脯氨酸3,-(2-二噻吩基)丙氨酸5,8,D-苯丙氨酸7)-舒緩激肽 | (1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ; N-ADAMANTANEACETYL-DARG-ARG-PRO-HYP-GLY-THI-SER-DPHE-THI-ARG; [N-admantaneACETYL-DARG0-HYP3,THI5,8,DPHE7] BRADYKININ; N-ALPHA-ADAMANTANEACETYL-D-ARG-ARG-PRO-HYDROXY-PRO-GLY-BETA-[2-THIENYL]ALA-SER-D-PHE-BETA-[2-THIENYL]ALA-ARG; N-ALPHA-ADAMANTANEACETYL-D-ARG-[HYP3,THI5,8,D-PHE7]-BRADYKININ; (1-ADAMANTANEACETYL-D-ARG0,HYP3,3-ALA(2-THIENYL)5,8,D-PHE7)-BRADYKININ; (1-ADAMANTANEACETYL-D-ARG0,HYP3,BETA-(2-THIENYL)-ALA5,8,D-PHE7)-BRADYKININ; 1-ADAMANTANEACETYL-D-ARG-ARG-PRO-HYP-GLY-3-ALA(2-THIENYL)-SER-D-PHE-3-ALA(2-THIENYL)-ARG-OH; 1-ADAMANTANEACETYL-D-ARG-ARG-PRO-HYP-GLY-BETA-(2-THIENYL)-ALA-SER-D-PHE-BETA-(2-THIENYL)-ALA-ARG |  | C68H99N19O14S2 | 詳情 | 供應商 |